A trial participant in remission criticizes saline placebos for cancer patients
The participant describes a three-year blinded placebo trial requiring monthly travel for treatment, saying they may be receiving saline despite hoping to get the drug.
TLDR
A trial participant says they are in remission and enrolled in a three-year, 50/50 blinded placebo trial. They want the drug but also want to advance science, crediting women in the previous generation for doing the same to help them. Being in remission makes the stakes feel tolerable, they say. Still, they argue that “no cancer patient should get saline” and express hope that embracing AI in biology could help many people.
Combined views
—
1 Source, first seen ago
